Skip to main content Skip to section navigation Skip to footer
Avalon GloboCare Corp.
  • Home
  • About
    • Overview
    • Executive Team
    • Board of Directors
  • Core Platforms
  • Investors
    • Overview
    • News & Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Information
    • Overview
    • Executive Team
    • Contacts
    • FAQ
  • Financial Information
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Corporate Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Jun 16, 2020 9:00am EDT

Eminent Member of the Austrian Academy of Sciences, Professor Uwe B. Sleytr, Joins Avalon GloboCare's Scientific and Clinical Advisory Board

Jun 11, 2020 9:00am EDT

Avalon GloboCare Announces Three-Way Material Transfer Agreement with Weill Cornell Medicine and Arbele Limited for Development of Next Generation Cellular Immunotherapy FLASH-CAR™ Technology

Jun 08, 2020 9:00am EDT

Avalon GloboCare Announces Diagnostic Platform for Point-of-Care Rapid Detection of COVID-19 (SARS-CoV-2) and Its Clinically Relevant Mutation Strains

May 08, 2020 9:00am EDT

Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers

Apr 28, 2020 9:00am EDT

Avalon GloboCare Partners with HydroPeptide, a Leader in Epigenetics Skin Care, to Accelerate Regenerative ACTEX™ Product Development and Commercialization

Apr 20, 2020 8:30am EDT

Avalon GloboCare Achieves Major Milestones Advancing Immunotherapeutic Program towards Combatting Cytokine Storm Associated with COVID-19 Lung Damage and Mortality

Feb 24, 2020 8:30am EST

Avalon GloboCare to Present at the 32nd Annual ROTH Conference on March 16, 2020

Jan 06, 2020 8:30am EST

Avalon GloboCare to Present at Biotech Showcase™ 2020

Dec 20, 2019 8:30am EST

Avalon GloboCare Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines

Nov 20, 2019 8:30am EST

Avalon GloboCare to Present at the 12th Annual LD Micro Main Event on December 10th

  • Previous Pagearrow_back
  • Page 1…
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
©2025 Avalon GloboCare Corp. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences